 canadian atrial fibril anticoagul cafa studi canadian atrial fibril anticoagul studi random double-blind placebo-control trial potenti warfarin system thromboembol inher risk hemorrhag result public posit studi similar design object studi complet plan recruit patient patient perman discontinu studi medic warfarin-tr placebo-tr patient target rang intern normal ratio warfarin-tr patient intern normal ratio target studi day studi day studi day fatal major bleed annual rate warfarin-tr placebo-tr patient minor bleed patient warfarin placebo primari outcom event cluster nonlacunar stroke noncentr nervou system embol fatal intracrani hemorrhag event primari analysi efficaci day perman discontinu studi medic annual rate primari outcom event cluster warfarin-tr placebo-tr patient rel risk reduct confid limit